Overview

September 23-24: Conference

Clinical trial information transparency is taking on new dimensions. Clinical trial sponsors and academia are facing a host of new registration requirements in the US, EU, and elsewhere. With evolving requirements comes new challenges, creating additional opportunities for knowledge-sharing and necessitating more interaction with peers. This conference will provide critical and timely information relating to global clinical trial disclosure and data transparency from those on the front lines.

While we develop our 2024 agenda, please take a moment to review the 2021 final agenda.

Participant Testimonials

Thanks for organizing such a nice conference on CTD and Trial Transparency. It was my first experience attending the DIA conference and I learnt new initiatives taken across industry.” – Ravi Jogai, Associate Director - Syneos Health (Seasoned Clinical Research Professional)

Featured

Want to learn more about Global Clinical Trial Disclosure and Data Transparency Conference? You've come to the right site!

Who should attend?

Conference Designed For:
- Academia
- Biometrics
- Clinical Operations / Development
- Clinical Trial Disclosure
- Clinical/Medical Research
- Compliance/Legal
- Data management
- Data transparency/data sharing
- External Health Authorities (comp and ethics committees)
- Internal Regulatory / Regulatory Submissions/Regulatory Leads
- Medical Writing, Medical Affairs, and Medical Communications
- Patient Advocacy
- Patient registries
- Publications
- Real-World Data
- Transparency policies and compliance (Clinical Data)

Program Committee

Robert Paarlberg, MS Principal
Paarlberg & Associates LLC, United States
Kelly Coulbourne, MS Director, Clinical Trial Disclosure and Data Transparency
Pfizer Inc, United States
Scott Feiner Senior Manager, Trial Disclosure
AbbVie, United States
Francine Lane, MBA Senior Director of Product Management
Citeline, United States
Pritibha Singh, MBA, MSc Senior Manager, Corporate Affairs Analytics & Insights
Novartis AG, Switzerland
Merete Joergensen, MBA, MSc Clinical Disclosure and Transparency Expert, Former EFPIA, CREG Clinical Trials
Merete-J Consulting CVR: 34920818, Denmark